5XS2 Stock Overview
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
LexaGene Holdings Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CA$0.084 |
| 52 Week High | CA$0.21 |
| 52 Week Low | CA$0.041 |
| Beta | 2.25 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -37.37% |
| 3 Year Change | -84.62% |
| 5 Year Change | -89.60% |
| Change since IPO | -50.41% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5XS2 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | -0.8% |
| 1Y | -37.4% | -3.3% | 1.0% |
Return vs Industry: 5XS2 underperformed the German Medical Equipment industry which returned -2.5% over the past year.
Return vs Market: 5XS2 underperformed the German Market which returned 5.9% over the past year.
Price Volatility
| 5XS2 volatility | |
|---|---|
| 5XS2 Average Weekly Movement | n/a |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 4.9% |
| 10% most volatile stocks in DE Market | 9.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5XS2's share price has been volatile over the past 3 months.
Volatility Over Time: Insufficient data to determine 5XS2's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2007 | 33 | Jack Regan | www.lexagene.com |
LexaGene Holdings Inc., a biotechnology company, engages in the research, development, and commercialization of pathogen detection systems. It offers MiQLab, an automated pathogen detection system that aims to transform pathogen detection in veterinary diagnostics, human clinical diagnostics, food and water safety testing, and other life sciences markets; and assay panels. Its automated pathogen detection platform is used at the site of sample collection, which offers unprecedented ease-of-use, sensitivity, and breadth of pathogen detection.
LexaGene Holdings Inc. Fundamentals Summary
| 5XS2 fundamental statistics | |
|---|---|
| Market cap | €10.13m |
| Earnings (TTM) | -€7.90m |
| Revenue (TTM) | €96.51k |
104.9x
P/S Ratio-1.3x
P/E RatioIs 5XS2 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5XS2 income statement (TTM) | |
|---|---|
| Revenue | US$104.27k |
| Cost of Revenue | US$757.46k |
| Gross Profit | -US$653.19k |
| Other Expenses | US$7.89m |
| Earnings | -US$8.54m |
Last Reported Earnings
Nov 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.061 |
| Gross Margin | -626.46% |
| Net Profit Margin | -8,189.91% |
| Debt/Equity Ratio | 66.4% |
How did 5XS2 perform over the long term?
See historical performance and comparison